ESP's core products include Cardene(R) IV, an intravenous hypertensive drug acquired from Wyeth (NYSE:WYE), and IV Busulfex(R), a treatment for bone marrow transplants, acquired from Orphan Medical (NASDAQ:ORPH). Also, within two years of initiating operations, ESP established a product pipeline consisting of one Phase III compound and two developmental drugs that are candidates for 505(b)(2) "paper filings." Today, under Mr. Spitznagel's leadership, the ESP team has grown to over 100 people, including nearly 60 hospital sales representatives.. Sadly though I didn't pull all my investments in January and I've been at the mercy of this wholesale jerseys from china market since then. It makes me weary of this bull run. I want it to keep climbing with stable numbers but I feel a bear trap is coming. Such bans can have implications beyond state lines. Atwood describes a case involving neglectful parents who had one child removed from their home when they were li...